Sign in
Explore the registryTrack Tarlatamab's trials

DeLLphi-306

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

TarlatamabOngoingActive not recruitingPhase 3Open NCT06117774 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…